2025
Pheochromocytoma and MEN Syndromes
Carr Z, Farela A, Oprea A. Pheochromocytoma and MEN Syndromes. 2025, 333-342. DOI: 10.1093/med/9780190902001.003.0030.Peer-Reviewed Original ResearchMultiple endocrine neoplasiaInadequate surgical resectionManagement of PPGLsRare neuroendocrine tumorsDefinitive surgical managementResection of pheochromocytomaPreoperative medical managementDiligent postoperative careHigh-risk procedurePersistent vasoplegiaResected patientsSurgical resectionNeuroendocrine tumorsPostoperative bleedingRefractory hypertensionVasopressor supportHypertensive crisisPreoperative optimizationEndocrine neoplasiaABSTRACT PheochromocytomaPostoperative periodPerioperative considerationsVentricular dysrhythmiasAnesthesia techniquesPotential complications
2022
Preoperative Management of Medications for Rheumatologic and HIV Diseases: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement
Russell LA, Craig C, Flores EK, Wainaina JN, Keshock M, Kasten MJ, Hepner DL, Edwards AF, Urman RD, Mauck KF, Oprea AD. Preoperative Management of Medications for Rheumatologic and HIV Diseases: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. Mayo Clinic Proceedings 2022, 97: 1551-1571. PMID: 35933139, DOI: 10.1016/j.mayocp.2022.05.002.Peer-Reviewed Original ResearchConceptsPerioperative medication managementPerioperative assessmentConsensus statementPreoperative managementMedication managementQuality Improvement (SPAQI) Consensus StatementEvidence-based perioperative careAnti-inflammatory medicationsPerioperative medical managementInfectious disease specialistsLong-term medicationInternal medicine physiciansComplexity of patientsPreoperative optimizationHIV diseaseCommon medicationsPerioperative careMedical managementDisease specialistsClinical guidanceConsensus recommendationsSurgical proceduresMedicine physiciansMedicationsExpert consensus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply